chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 54.0
Sex: F
Vaccine: FLUX, VARZOS, FLUX, VARZOS, FLUX, VARZOS
Symptoms: Sensory disturbance
Clinical narrative: This spontaneous report as received from a physician refers to a female patient of unknown age. On an unknown date the patient was vaccinated with ZOSTAVAX vial (strength, dose unit, route, lot# and expiry date unknown). On an unknown date after administering with ZOSTAVAX the patient experienced the following adverse reactions, that have last for more than three months including crawling feeling underneath her skin, bad blood circulation, joint pain, heart palpitations, it was hard for her to breath, pressure in head and ears, tightness in her bones, she felt discomfort, spicy feeling in her fingers and nerve throbbing in her legs. On unspecified dates, she has seen many doctors and was currently wearing a heart monitor because of these symptoms. Physician asked for the following information: Have there been any reports of patients experiencing neuropathic or neuralgia symptoms after receiving ZOSTAVAX and was there any treatment. Physician also asked if a patient could develop post-herpetic neuralgia from the ZOSTAVAX vaccine. The outcome of hard for her to breathe, nerve throbbing in her legs, spicy feeling in her fingers, feels discomfort, tightness in her bones, pressure in her head and ears, heart palpitations, joint pain, bad blood circulation and crawling feeling underneath her skin was unknown. Additional information has been requested.
Age: 54.0
Sex: F
Vaccine: FLUX, VARZOS, FLUX, VARZOS, FLUX, VARZOS
Symptoms: Arthralgia, Bone disorder, C-reactive protein normal, Cardiac monitoring, Cardiovascular disorder
Clinical narrative: This spontaneous report as received from a physician refers to a female patient of unknown age. On an unknown date the patient was vaccinated with ZOSTAVAX vial (strength, dose unit, route, lot# and expiry date unknown). On an unknown date after administering with ZOSTAVAX the patient experienced the following adverse reactions, that have last for more than three months including crawling feeling underneath her skin, bad blood circulation, joint pain, heart palpitations, it was hard for her to breath, pressure in head and ears, tightness in her bones, she felt discomfort, spicy feeling in her fingers and nerve throbbing in her legs. On unspecified dates, she has seen many doctors and was currently wearing a heart monitor because of these symptoms. Physician asked for the following information: Have there been any reports of patients experiencing neuropathic or neuralgia symptoms after receiving ZOSTAVAX and was there any treatment. Physician also asked if a patient could develop post-herpetic neuralgia from the ZOSTAVAX vaccine. The outcome of hard for her to breathe, nerve throbbing in her legs, spicy feeling in her fingers, feels discomfort, tightness in her bones, pressure in her head and ears, heart palpitations, joint pain, bad blood circulation and crawling feeling underneath her skin was unknown. Additional information has been requested.
Age: 54.0
Sex: F
Vaccine: FLUX, VARZOS, FLUX, VARZOS, FLUX, VARZOS
Symptoms: Discomfort, Dyspnoea, Ear discomfort, Fatigue, Formication
Clinical narrative: This spontaneous report as received from a physician refers to a female patient of unknown age. On an unknown date the patient was vaccinated with ZOSTAVAX vial (strength, dose unit, route, lot# and expiry date unknown). On an unknown date after administering with ZOSTAVAX the patient experienced the following adverse reactions, that have last for more than three months including crawling feeling underneath her skin, bad blood circulation, joint pain, heart palpitations, it was hard for her to breath, pressure in head and ears, tightness in her bones, she felt discomfort, spicy feeling in her fingers and nerve throbbing in her legs. On unspecified dates, she has seen many doctors and was currently wearing a heart monitor because of these symptoms. Physician asked for the following information: Have there been any reports of patients experiencing neuropathic or neuralgia symptoms after receiving ZOSTAVAX and was there any treatment. Physician also asked if a patient could develop post-herpetic neuralgia from the ZOSTAVAX vaccine. The outcome of hard for her to breathe, nerve throbbing in her legs, spicy feeling in her fingers, feels discomfort, tightness in her bones, pressure in her head and ears, heart palpitations, joint pain, bad blood circulation and crawling feeling underneath her skin was unknown. Additional information has been requested.
Age: 54.0
Sex: F
Vaccine: FLUX, VARZOS, FLUX, VARZOS, FLUX, VARZOS
Symptoms: Headache, Hyperuricaemia, Hypoaesthesia, Metabolic function test normal, Neuralgia
Clinical narrative: This spontaneous report as received from a physician refers to a female patient of unknown age. On an unknown date the patient was vaccinated with ZOSTAVAX vial (strength, dose unit, route, lot# and expiry date unknown). On an unknown date after administering with ZOSTAVAX the patient experienced the following adverse reactions, that have last for more than three months including crawling feeling underneath her skin, bad blood circulation, joint pain, heart palpitations, it was hard for her to breath, pressure in head and ears, tightness in her bones, she felt discomfort, spicy feeling in her fingers and nerve throbbing in her legs. On unspecified dates, she has seen many doctors and was currently wearing a heart monitor because of these symptoms. Physician asked for the following information: Have there been any reports of patients experiencing neuropathic or neuralgia symptoms after receiving ZOSTAVAX and was there any treatment. Physician also asked if a patient could develop post-herpetic neuralgia from the ZOSTAVAX vaccine. The outcome of hard for her to breathe, nerve throbbing in her legs, spicy feeling in her fingers, feels discomfort, tightness in her bones, pressure in her head and ears, heart palpitations, joint pain, bad blood circulation and crawling feeling underneath her skin was unknown. Additional information has been requested.
Age: 54.0
Sex: F
Vaccine: FLUX, VARZOS, FLUX, VARZOS, FLUX, VARZOS
Symptoms: Neuropathy peripheral, Pain, Palpitations, Paraesthesia, Red blood cell sedimentation rate normal
Clinical narrative: This spontaneous report as received from a physician refers to a female patient of unknown age. On an unknown date the patient was vaccinated with ZOSTAVAX vial (strength, dose unit, route, lot# and expiry date unknown). On an unknown date after administering with ZOSTAVAX the patient experienced the following adverse reactions, that have last for more than three months including crawling feeling underneath her skin, bad blood circulation, joint pain, heart palpitations, it was hard for her to breath, pressure in head and ears, tightness in her bones, she felt discomfort, spicy feeling in her fingers and nerve throbbing in her legs. On unspecified dates, she has seen many doctors and was currently wearing a heart monitor because of these symptoms. Physician asked for the following information: Have there been any reports of patients experiencing neuropathic or neuralgia symptoms after receiving ZOSTAVAX and was there any treatment. Physician also asked if a patient could develop post-herpetic neuralgia from the ZOSTAVAX vaccine. The outcome of hard for her to breathe, nerve throbbing in her legs, spicy feeling in her fingers, feels discomfort, tightness in her bones, pressure in her head and ears, heart palpitations, joint pain, bad blood circulation and crawling feeling underneath her skin was unknown. Additional information has been requested.
Age: 54.0
Sex: F
Vaccine: FLUX, VARZOS, FLUX, VARZOS, FLUX, VARZOS
Symptoms: White blood cell count decreased
Clinical narrative: This spontaneous report as received from a physician refers to a female patient of unknown age. On an unknown date the patient was vaccinated with ZOSTAVAX vial (strength, dose unit, route, lot# and expiry date unknown). On an unknown date after administering with ZOSTAVAX the patient experienced the following adverse reactions, that have last for more than three months including crawling feeling underneath her skin, bad blood circulation, joint pain, heart palpitations, it was hard for her to breath, pressure in head and ears, tightness in her bones, she felt discomfort, spicy feeling in her fingers and nerve throbbing in her legs. On unspecified dates, she has seen many doctors and was currently wearing a heart monitor because of these symptoms. Physician asked for the following information: Have there been any reports of patients experiencing neuropathic or neuralgia symptoms after receiving ZOSTAVAX and was there any treatment. Physician also asked if a patient could develop post-herpetic neuralgia from the ZOSTAVAX vaccine. The outcome of hard for her to breathe, nerve throbbing in her legs, spicy feeling in her fingers, feels discomfort, tightness in her bones, pressure in her head and ears, heart palpitations, joint pain, bad blood circulation and crawling feeling underneath her skin was unknown. Additional information has been requested.
Age: 54.0
Sex: F
Vaccine: FLUX, VARZOS, FLUX, VARZOS, FLUX, VARZOS
Symptoms: Antineutrophil cytoplasmic antibody, Arthralgia, C-reactive protein normal, Discomfort, Dyspnoea
Clinical narrative: This spontaneous report as received from a physician refers to a female patient of unknown age. On an unknown date the patient was vaccinated with ZOSTAVAX vial (strength, dose unit, route, lot# and expiry date unknown). On an unknown date after administering with ZOSTAVAX the patient experienced the following adverse reactions, that have last for more than three months including crawling feeling underneath her skin, bad blood circulation, joint pain, heart palpitations, it was hard for her to breath, pressure in head and ears, tightness in her bones, she felt discomfort, spicy feeling in her fingers and nerve throbbing in her legs. On unspecified dates, she has seen many doctors and was currently wearing a heart monitor because of these symptoms. Physician asked for the following information: Have there been any reports of patients experiencing neuropathic or neuralgia symptoms after receiving ZOSTAVAX and was there any treatment. Physician also asked if a patient could develop post-herpetic neuralgia from the ZOSTAVAX vaccine. The outcome of hard for her to breathe, nerve throbbing in her legs, spicy feeling in her fingers, feels discomfort, tightness in her bones, pressure in her head and ears, heart palpitations, joint pain, bad blood circulation and crawling feeling underneath her skin was unknown. Additional information has been requested.
Age: 54.0
Sex: F
Vaccine: FLUX, VARZOS, FLUX, VARZOS, FLUX, VARZOS
Symptoms: Electrophoresis protein, Fatigue, Formication, Full blood count normal, Headache
Clinical narrative: This spontaneous report as received from a physician refers to a female patient of unknown age. On an unknown date the patient was vaccinated with ZOSTAVAX vial (strength, dose unit, route, lot# and expiry date unknown). On an unknown date after administering with ZOSTAVAX the patient experienced the following adverse reactions, that have last for more than three months including crawling feeling underneath her skin, bad blood circulation, joint pain, heart palpitations, it was hard for her to breath, pressure in head and ears, tightness in her bones, she felt discomfort, spicy feeling in her fingers and nerve throbbing in her legs. On unspecified dates, she has seen many doctors and was currently wearing a heart monitor because of these symptoms. Physician asked for the following information: Have there been any reports of patients experiencing neuropathic or neuralgia symptoms after receiving ZOSTAVAX and was there any treatment. Physician also asked if a patient could develop post-herpetic neuralgia from the ZOSTAVAX vaccine. The outcome of hard for her to breathe, nerve throbbing in her legs, spicy feeling in her fingers, feels discomfort, tightness in her bones, pressure in her head and ears, heart palpitations, joint pain, bad blood circulation and crawling feeling underneath her skin was unknown. Additional information has been requested.
Age: 54.0
Sex: F
Vaccine: FLUX, VARZOS, FLUX, VARZOS, FLUX, VARZOS
Symptoms: Hypoaesthesia, Immunisation reaction, Malaise, Metabolic function test normal, Palpitations
Clinical narrative: This spontaneous report as received from a physician refers to a female patient of unknown age. On an unknown date the patient was vaccinated with ZOSTAVAX vial (strength, dose unit, route, lot# and expiry date unknown). On an unknown date after administering with ZOSTAVAX the patient experienced the following adverse reactions, that have last for more than three months including crawling feeling underneath her skin, bad blood circulation, joint pain, heart palpitations, it was hard for her to breath, pressure in head and ears, tightness in her bones, she felt discomfort, spicy feeling in her fingers and nerve throbbing in her legs. On unspecified dates, she has seen many doctors and was currently wearing a heart monitor because of these symptoms. Physician asked for the following information: Have there been any reports of patients experiencing neuropathic or neuralgia symptoms after receiving ZOSTAVAX and was there any treatment. Physician also asked if a patient could develop post-herpetic neuralgia from the ZOSTAVAX vaccine. The outcome of hard for her to breathe, nerve throbbing in her legs, spicy feeling in her fingers, feels discomfort, tightness in her bones, pressure in her head and ears, heart palpitations, joint pain, bad blood circulation and crawling feeling underneath her skin was unknown. Additional information has been requested.
Age: 54.0
Sex: F
Vaccine: FLUX, VARZOS, FLUX, VARZOS, FLUX, VARZOS
Symptoms: Paraesthesia, Pruritus, Red blood cell sedimentation rate normal, Rheumatoid factor, Varicella virus test
Clinical narrative: This spontaneous report as received from a physician refers to a female patient of unknown age. On an unknown date the patient was vaccinated with ZOSTAVAX vial (strength, dose unit, route, lot# and expiry date unknown). On an unknown date after administering with ZOSTAVAX the patient experienced the following adverse reactions, that have last for more than three months including crawling feeling underneath her skin, bad blood circulation, joint pain, heart palpitations, it was hard for her to breath, pressure in head and ears, tightness in her bones, she felt discomfort, spicy feeling in her fingers and nerve throbbing in her legs. On unspecified dates, she has seen many doctors and was currently wearing a heart monitor because of these symptoms. Physician asked for the following information: Have there been any reports of patients experiencing neuropathic or neuralgia symptoms after receiving ZOSTAVAX and was there any treatment. Physician also asked if a patient could develop post-herpetic neuralgia from the ZOSTAVAX vaccine. The outcome of hard for her to breathe, nerve throbbing in her legs, spicy feeling in her fingers, feels discomfort, tightness in her bones, pressure in her head and ears, heart palpitations, joint pain, bad blood circulation and crawling feeling underneath her skin was unknown. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Injection site reaction, Local reaction
Clinical narrative: This spontaneous report as received from a physician refers to an unspecified number of patients of unknown age and gender with no medical history and drug reactions or allergies reported. On unspecified dates, the patients were vaccinated with VARIVAX (dose, lot number, expiration date and route of administration not reported). No concomitant medications were reported. The reporter stated that patients experienced local reactions further described as injection site reactions a couple of days after the administration of VARIVAX. The physician did not recall specific patients or specific patients' details. The outcome of injection site reaction was unknown. The relatedness between injection site reaction and VARIVAX was not reported. Additional information has been requested.
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash pruritic
Clinical narrative: Pt noticed a rash all over back & down left side that itches. Raised, but no oozing.  No fever. Dr. said to used Benadryl tablets and Gold Bond anti-itch cream.
Age: 0.51
Sex: F
Vaccine: DTAP, FLUX, HIBV, IPV, MMR, RVX, VARCEL
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: Patient was 6 months, but was giving vaccinations that where meant for a 1 year old for chickenpox and the MMR. Patient was also given her regular 6 months shots additionally.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Furuncle, Rash, Urticaria
Clinical narrative: 3 weeks after vaccine, developed rash on neck up to jaw line that kept getting worse, Dr prescribed a steroid cream; also got a large boil on back of head that took 4 to 6 weeks to heal; also developed hives different than the rash- still have them currently everyday.
Age: 5.0
Sex: F
Vaccine: PPV
Symptoms: Chills, Pyrexia
Clinical narrative: Patient awoke with chills and fever on evening following vaccine. TMAX 103.  Fever resolved within next hours. Patient well the following morning.
Age: 0.17
Sex: M
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Dehydration, Diarrhoea, Hypophagia
Clinical narrative: Pt received ROTATEQ vaccine on 10-24-13 and 48-72 hrs. later developed decreased po intake and diarrhea resulting in dehydration requiring a 3 day hospitalization for observation and IV fluids.
Age: 65.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema
Clinical narrative: Patient c/o redness at injection site. Applied Benadryl cream and symptoms improved. Patient called pharmacy on 2/24/14 to report adverse reaction. Pharmacy asked her to follow up with primary care provider.
Age: 1.51
Sex: M
Vaccine: DTAP, HIBV, MMR
Symptoms: Dermatitis diaper
Clinical narrative: First diaper rash ever! No other changes in diet or clothing have been made.
Age: 13.0
Sex: F
Vaccine: HPV4
Symptoms: Idiopathic thrombocytopenic purpura
Clinical narrative: IDIOPATHIC THROMBOCYTOPENIC PURPURA.
Age: 67.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain
Clinical narrative: Flu injection painful and began to be sore at once. It is now approximately 3 months later and the arm where the vaccine was given is still achy, painful, sore intermittently. Entire upper arm and shoulder affected.
Age: 70.0
Sex: M
Vaccine: PPV
Symptoms: Ear swelling, Erythema, Pain in extremity
Clinical narrative: Intense pain in left arm for 2 days (42-72 hours) after vaccine starting at 3 AM. Arm knotted up and pain from shoulder to elbow. Patient had skin cancer surgery on left neck/ear on same day he got vaccine. One earlobe was red and enlarged and possibly infected not sure if earlobe symptoms tied to vaccine.
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site pruritus, Injection site rash, Injection site warmth
Clinical narrative: Pt has a rash at injection site. It is warm to touch, itchy (as per pt) and about 2" x 3". Pt advised to take Diphenhydramine and to see a physician if condition worsens. Pt took Benadryl; "still looks the same" 8:39 PM 2/25/14.
Age: 76.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site pain
Clinical narrative: Patient states he has continuous arm pain at injection site uses heating pad to relieve pain. Pt followed up with physician, who, according to the patient did not address issue. Patient has history of back pain from previous unrelated injury. Person spoke with nurse at physician's office 2/25/14. Nurse said patient has been complaining of back pain with no mention of arm pain.
Age: 48.0
Sex: U
Vaccine: PPV
Symptoms: Cellulitis, Chills, Infection, Pain, Pyrexia
Clinical narrative: Arm infected - fever, chills, painful, rash. Pt. stated she had cellulitis and treated pt with antibiotics. Pt. stated no SOB.
Age: 48.0
Sex: U
Vaccine: PPV
Symptoms: Rash
Clinical narrative: Arm infected - fever, chills, painful, rash. Pt. stated she had cellulitis and treated pt with antibiotics. Pt. stated no SOB.
Age: 56.0
Sex: F
Vaccine: VARZOS
Symptoms: Gingival bleeding, Injection site erythema, Oral pain
Clinical narrative: Erythema around injection site. Oral sensitivity and pain with gingival bleeding beginning day after injection.
Age: 9.0
Sex: M
Vaccine: VARCEL
Symptoms: Erythema, Inflammation, Poor quality sleep, Pruritus
Clinical narrative: 9 y/o male received vaccine (Varicella) yesterday during well exam. Took shower last night - arm itchy and didn't sleep well. Left arm initially look like had a long bite but this morning bigger 1.5 x 2.5 in erythema/inflammation. No induration. No tenderness. evid of infection. No meds given and no ice applied.
Age: 45.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site pain, Pruritus, Skin exfoliation, Skin fissures
Clinical narrative: Flu administered IM 12/2/13. C/O pain left shoulder. 12/3/13 Itchy skin -> peeling and cracking skin. Treated with BENADRYL and "lotion".
Age: 11.0
Sex: M
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Pharmacist concerning an 11 year old, male subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on 27-Nov-2013. The pharmacist reported that inadvertently administered expired FLUMIST QUADRIVALENT to a patient on 27-Nov-2013. The outcome of the event of administration of expired FLUMIST is unknown. The report was considered to be non-serious. Summary of significant follow-up information received by AstraZeneca/MedImmune on 03-Dec-2013 from a Pharmacist: Product lot number ane expiry date added with updation of start date for FLUMIST. Event start date updated. Patient details updated. Reporter details updated.
Age: 1.12
Sex: F
Vaccine: HEPA, MMRV, PNC13
Symptoms: Eating disorder, Pyrexia, Rash
Clinical narrative: Fever, rash, refusal to eat - vaccine given 2/12/14. Symptoms started 2/22/14.
Age: 71.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: Swelling, redness, heat, and hardness in large circle around injection site. Total redness site was approx 7-8 inches in diameter.
Age: 11.0
Sex: M
Vaccine: FLUN4
Symptoms: Expired drug administered, No adverse event
Clinical narrative: A report has been received from a Health Professional concerning an 11 year old, Male subject, who had been receiving FLUMIST quadrivalent (intranasal). FLUMIST quadrivalent (intranasal) started on 02-Dec-2013. The medical assistant reported that six patients received FLUMIST quadrivalent that expired on 25-Nov-2013 on 02-Dec-2013. Not reporting any symptoms. The outcome of the event of administration of expired product is unknown. The report was considered to be non-serious by reporter.
Age: 30.0
Sex: F
Vaccine: TYP
Symptoms: Abdominal pain, Diarrhoea, Nausea
Clinical narrative: Patient experienced nausea, soft stools, abdominal pain.
Age: 11.0
Sex: F
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning an 11 year old, Female subject, who had been receiving FLUMIST quadrivalent (intranasal). FLUMIST quadrivalent (intranasal) started on an unknown date. The health professional reported that patient received expired FLUMIST quad on 02-Dec-2013. The outcome of the event of administration of expired product is unknown. The report was considered to be non-serious.
Age: 65.0
Sex: M
Vaccine: PPV
Symptoms: Feeling hot, Myalgia, Pyrexia
Clinical narrative: Pt states he had severe muscle ache, in his left arm, most likely had a fever (felt hot) slept 14 hours that night, the next day was 75% improved. Took 3 days until gone. No swelling, redness on arm.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: This spontaneous report was received from a Nurse refers to a patient of unknown demography. The nurse reported that the patient was vaccinated a dose of GARDASIL, 0.5 ml, intramuscular on 14-JUL-2009, 21-SEP-2009, 26-JUL-2011, 18-OCT-2013 and on 21-FEB-2014. No adverse events were reported. Additional information has been requested.
Age: 8.0
Sex: F
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning an 8 year old, female subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on an unknown date. On 02-Dec-2013, the patient received FLUMIST QUAD that expired on 25-Nov-2013. The outcome of the event of administration of expired product was unknown. The report was considered to be non-serious.
Age: 2.0
Sex: M
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning a 2 year old, Male subject, who had been receiving FLUMIST quadrivalent (intranasal). FLUMIST (intranasal) started on an unknown date. The reporter reported that we inadvertently gave an expired dose of FLUMIST which started on 03-Dec-2013. The outcome of the event of inadvertently gave an expired dose of FLUMIST was unknown. The report was considered to be non-serious by reporter.
Age: 0.72
Sex: M
Vaccine: FLUN4
Symptoms: Expired drug administered, No adverse event
Clinical narrative: A report has been received from a Health Professional concerning an 8 month old, male subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST started on 02-Dec-2013. It was reported that the patient was inadvertently administered expired FLUMIST QUADRIVALENT on 02-Dec-2013. No adverse reaction has occurred. The outcome of the event of inadvertent administration of expired FLUMIST is unknown. The report was considered to be non-serious.
Age: 4.0
Sex: F
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning a 4 year old, Female subject, who had been receiving FLUMIST quadrivalent (intranasal). FLUMIST quadrivalent (intranasal) started on 04-Dec-2013. It was reported that four patients were inadvertently administered expired FLUMIST quadrivalent which started on 04-Dec-2013. The outcome of the event of inadvertently administered expired FLUMIST quadrivalent to four patients is unknown. The report was considered to be non-serious.
Sex: U
Vaccine: FLUN4
Symptoms: Influenza A virus test positive, Influenza B virus test positive
Clinical narrative: A report has been received from a Physician concerning, subject of unknown gender, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST started on 24-Sep-2013. The patient experienced tested positive for Influenza A and B, positive for flu B which started on 27-Sep-2013. The outcome of the event of tested positive for influenza A and B, positive for flu B is unknown. The report was considered to be non-serious.
Age: 6.0
Sex: M
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning a 6 year old, Male subject, who had been receiving FLUMIST quadrivalent (intranasal). FLUMIST (intranasal) started on 03-Dec-2013. The registered nurse reported that they inadvertently gave a dose of expired FLUMIST on 03-Dec-2013. The patient has not reported any symptoms. The outcome of the event of inadvertently gave a dose of expired FLUMIST is unknown. The report was considered to be non-serious.
Age: 4.0
Sex: F
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning a 4 year old, Female subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on 25-Nov-2013. The health professional reported that they inadvertently gave FLUMIST which started on 25-Nov-2013. The outcome of the event of We Inadvertently Gave FLUMIST is unknown. The report was considered to be non-serious.
Age: 3.0
Sex: M
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning a 3 year old, Male subject, who had been receiving FLUMIST quadrivalent (intranasal). FLUMIST quadrivalent (intranasal) started on an unknown date. The health professional reported that patient had administration of an expired dose which started on 26-Nov-2013. The outcome of the event of administration of an expired dose is unknown. The report was considered to be non-serious.
Age: 2.0
Sex: F
Vaccine: FLUN4
Symptoms: Expired drug administered, Underdose
Clinical narrative: A report has been received from a Health Professional concerning a 2 year old, female subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on 03-Dec-2013. Medical assistant reported that they inadvertently administered half of an expired dose of FLUMIST QUADRIVALENT to a patient on 03-Dec-2013. The outcome of the event of inadvertently administered 1/2 of an expired dose of FLUMIST QUADRIVALENT to a patient is unknown. The report was considered to be non-serious.
Age: 34.0
Sex: F
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning a 34 year old, Female subject, who had been receiving FLUMIST quadrivalent (intranasal). FLUMIST quadrivalent (intranasal) started on 26-Nov-2013. One patient received expired FLUMIST which started on 26-Nov-2013.l The outcome of the event of one patient received expired FLUMIST is unknown. The report was considered to be non-serious by the reporter.
Age: 39.0
Sex: F
Vaccine: FLUN4
Symptoms: Incorrect dose administered
Clinical narrative: A report has been received from a Pharmacist concerning a 39 year old, female subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on 11-Nov-2013. The reporter stated that the patient had administration of only a half dose of FLUMIST in one nostril which started on 11-Nov-2013. The outcome of the event of administration of only a half dose of FLUMIST in one is unknown. The report was considered to be non-serious.
Age: 5.0
Sex: F
Vaccine: FLUN4
Symptoms: Expired drug administered, No adverse event
Clinical narrative: A report has been received from a Health Professional concerning a 5 year old, Female subject, who had been receiving FLUMIST, (intranasal). FLUMIST started on an unknown date. The reporter stated that patient was inadvertently administered expired FLUMIST on 26-Nov-2013. No adverse reaction had occurred. The outcome of the event of expired FLUMIST is unknown. The report was considered to be non-serious.
Age: 8.0
Sex: M
Vaccine: FLUN4
Symptoms: Expired drug administered, No adverse event
Clinical narrative: A report has been received from a Health Professional concerning an 8 year old, Male subject, who had been receiving Nasal FLUMIST. FLUMIST started on an unknown date. Practice manager reported that they accidentally gave FLUMIST to a patient on 26-Nov-2013. The patient had not reported any symptoms. The outcome of the event of ACCIDENTALLY GAVE EXPIRED FLUMIST is unknown. The report was considered to be non-serious.
Age: 42.0
Sex: F
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning a, Female subject, who had been receiving FLUMIST, (intranasal). FLUMIST started on an unknown date. The patient experienced expired FLUMIST. The outcome of the event of expired FLUMIST is unknown. The report was considered to be non-serious.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: This spontaneous report as received from a physician, via a company representative refers to a female patient of unknown age "who is over 60 years old". The patient had a history of "multi-melanoma remission patient". On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (dose, route and frequency were not reported). On an unknown date "two weeks after the patient received ZOSTAVAX", she developed shingles. On an unspecified date, the patient was admitted to the hospital in regards to this reaction. It was reported that no intervention to prevent serious criteria was needed. At the time of the report, the patient was recovering from the event of shingles: "she was ok". Additional information has been requested.
Sex: M
Vaccine: VARZOS
Symptoms: Unevaluable event
Clinical narrative: Information has been received from an agency representing a pharmacy in regards to a male patient who in approximately November 2013, received a dose of ZOSTAVAX (lot # J006830, expiration 14-SEP-2014) (exact date of administration, site and dose not reported). It was reported that on 02-NOV-2013, the patient was hospitalized shortly after receiving his dose of ZOSTAVAX. The reason for the hospitalization was not reported. No medical history was provided. No additional information was reported. Additional information is not expected.
Age: 29.0
Sex: M
Vaccine: VARZOS
Symptoms: Drug administered to patient of inappropriate age, No adverse event
Clinical narrative: This spontaneous report was received from a pharmacist refers to a 29 year old male patient. On an unknown date, the 29 year old male patient was vaccinated with ZOSTAVAX (dose, route and frequency were not reported) Inappropriate schedule of vaccine administered). No adverse effects reported. No further information provided. Additional information has been requested.
Age: 0.53
Sex: U
Vaccine: RV5
Symptoms: Expired drug administered, No adverse event
Clinical narrative: This spontaneous report as received from a other health professional refers to a 6 month old patient who on 20-FEB-2014, was vaccinated with a 2.0 ml dose of ROTATEQ oral (lot number H012252) that was expired. The vaccine expired on 29-JAN-2014. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
Age: 0.23
Sex: F
Vaccine: RV5
Symptoms: Expired drug administered, No adverse event
Clinical narrative: This spontaneous report as received from a other health professional refers to a 12 week old patient who on 19-FEB-2014, was vaccinated with a 2.0 ml dose of ROTATEQ oral (lot number H012252) that was expired. The vaccine expired on 29-JAN-2014. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
Age: 0.35
Sex: U
Vaccine: RV5
Symptoms: Expired drug administered, No adverse event
Clinical narrative: This spontaneous report as received from a other health professional refers to a 4 month old patient who on 19-FEB-2014, was vaccinated with a 2.0 ml dose of ROTATEQ oral (lot number H012252) that was expired. The vaccine expired on 29-JAN-2014. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: This spontaneous report was received from a physician refers to a patient of unknown age. On an unknown date the patient was vaccinated with ZOSTAVAX (dose, route and frequency were not reported). On an unknown date, the patient experienced patient developed a mild case of shingles. The outcome of patient developed a mild case of shingles was unknown. The reporter did not provide the causality between the event and the suspect drug. This case is linked to the case 1402USA011436 (same reporter link). Additional information has been requested.
Age: 8.0
Sex: F
Vaccine: FLUN4
Symptoms: Circumstance or information capable of leading to medication error, Exposure via direct contact, Underdose
Clinical narrative: A report has been received from a Health Professional concerning an 8 year old, Female subject, who had been receiving Nasal FLUMIST. FLUMIST QUADRIVALENT started on 17-Oct-2013. It was reported that while administering FLUMIST QUADRIVALENT on 17-Oct-2013, a patient jerked and not all of the FLUMIST QUADRIVALENT was administered into the second nostril, a portion of the FLUMIST went into the face and eye. Patient has not had any symptoms or complaints from eye exposure. The first nostril was successful. FLUMIST QUADRIVALENT was discontinued on 17-Oct-2013. The outcome of the event of PATIENT JERKED AND SOME FLUMIST WENT INTO THE FACE AND EYE and NOT ALL OF THE FLUMIST QUADRIVALENT WAS ADMINISTERED is unknown. The report was considered to be non-serious.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: This spontaneous report was received from a physician refers to a patient of unknown age. On an unknown date the patient was vaccinated with ZOSTAVAX (dose, route and frequency were not reported). On an unknown date, the patient experienced patient developed a mild case of shingles. The outcome of patient developed a mild case of shingles was unknown. The reporter did not provide the causality between the event and the suspect drug. This case is linked to the case 1402USA011857 (same reporter link). Additional information has been requested.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: This spontaneous report as received from a Medical assistant refers to a 64 year old female patient with no drug allergies or pertinent medical history who on 21-DEC-2009 the patient was vaccinated with ZOSTAVAX lot # 664277/0367Y, exp date 03-OCT-2010 (also reported as 30-JUL-2010), once, 0.5 ml, subcutaneous for she wanted to get it cause she had chicken pox as a child. Concomitant therapies included ALTACE, simvastatin (manufacturer unknown), FOSAMAX and hydrochlorothiazide (manufacturer unknown). The health care professional stated that the patient was seen in the office today 21-FEB-2014 and was "diagnosed with shingles". The medical assistant stated the "shingles started a week and a half ago" on approximately 11-FEB-2014. The medical assistant described that physician prescribed VALTREX. The outcome of event shingles was reported as not recovered/not resolved. Additional information has been requested.
Age: 15.0
Sex: M
Vaccine: HPV4
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: This spontaneous report as received from a Registered Nurse refers to a 15 year old male patient. On 20-AUG-2013, the patient was vaccinated with first dose of GARDASIL, on 05-SEP-2013, the patient was vaccinated with second dose of GARDASIL and on 08-OCT-2013, third dose of GARDASIL. No adverse effects reported. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Human papilloma virus test positive, Smear cervix abnormal
Clinical narrative: This spontaneous report as received from a female patient of unknown age refers to herself. The patient had tested positive for HPV in 2008. In 2009 the patient was vaccinated with series of GARDASIL (dose, route and lot number unspecified). The patient stated that throughout 2010 she had clean pap smears and no presence of HPV. Last week, in February 2014, she had a pap smear and tested positive for HPV. The outcome of the patient was unknown. The relationship was not assessed. Additional information is not expected.
Sex: U
Vaccine: MMR
Symptoms: Expired drug administered, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a patient of unknown age. On 19-FEB-2014 the patient was vaccinated with a dose of M-M-R (lot # unspecified, expiration date 01-FEB-2014), (dose and route unspecified). No adverse effects reported. Additional information has been requested.
Age: 18.0
Sex: F
Vaccine: PPV
Symptoms: Influenza like illness, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: This spontaneous report was received from a consumer (patient father) refers to a 18 year old female patient. On 18-FEB-2014, the patient was vaccinated with PNEUMOVAX 23 (dose, route and frequency were not reported). On 19-FEB-2014, 2 days after onset of therapy, the patient experienced injection site soreness, a red swelling area approximately 4 inches diameter and flu-like symptoms. The patient sought medical attention and contacted the physician to determine how long the events will last. The outcome of the events was reported as not recovered. The reporter did not provided the causality between the event and the suspect drug. Additional information has been requested.
Sex: M
Vaccine: ANTH, YF
Symptoms: Dizziness, Dyspnoea, Erythema, Flushing
Clinical narrative: Initial case received from a physician on 19 February 2014. A male patient, with no reported medical history or concomitant medications, received a dose of Yellow Fever Vaccine (lot number not reported) on an unspecified date in 2010. Approximately five to ten minutes post-vaccination, he began experiencing difficulty breathing, flushed, turned bright red, and became dizzy. He was treated with a "shot" reported as "probably epinephrine" by the reporter, and oxygen. Symptoms resolved with treatment. According to the reporter, who was an allergist, the patient was being evaluated for allergies. The event had been previously reported to VAERS under reference number 393515-1. The patient also received Anthrax (manufacturer, lot number not reported). The reporter did not provide contact information for follow-up questions. No additional information will be requested. No additional documents held by sender.
Age: 11.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Disability, Fatigue, Headache, Infectious mononucleosis
Clinical narrative: This spontaneous report as received from a pharmacist refers to a 11 year old female patient (daughter). The patients medical history included temporomandibular joint(June 2013). The patient, was administered her first dose of GARDASIL on 04-SEP-2013. On an unknown date in early October 2013, the patient developed a persistent headache. The patient was seen at a local urgent care facility on 27-Oct-2013 and was prescribed CEFDINIR for probable sinusitis. An unspecified physician added prednisone(manufacturer unknown) to therapy on 31-OCT-2013. The symptoms did not improve. In November 2013, a Computerised tomography scan of the head revealed swollen lymph nodes (disability). A mono test was positive. The patient has been on bed rest, unable to attend school, since November 2013. The patient was experiencing ear pain and extreme sensitivity to sound, intermittent nausea, and cold hands and feet. The outcome of swollen lymph nodes, cold hands and feet, intermittent nausea, extreme sensitivity to sound, ear pain and persistent headache was reported as not recovered. The causality for the events was not reported. Follow up information has been received from the pharmacist which stated that there has been no change to his daughter's condition. She was still bedridden, no energy and continued with the same symptoms for the last 4.5 months. The mononucleosis had been found following vaccination. The patient also had fatigue. The patient was having lab work done the day of the report. Results from MRI and CT scans (dates unspecified) were unremarkable. All reported events were considered as disability. It has been determined that case # 1402USA008807 is a duplicate of case # 1402USA004484. Therefore, case # 1402USA008807 is being deleted from our files and the cases consolidated into case # 1402USA004484. Additional information has been requested.
Age: 11.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Activities of daily living impaired, Asthenia, Bed rest, Computerised tomogram head abnormal, Ear pain
Clinical narrative: This spontaneous report as received from a pharmacist refers to a 11 year old female patient (daughter). The patients medical history included temporomandibular joint(June 2013). The patient, was administered her first dose of GARDASIL on 04-SEP-2013. On an unknown date in early October 2013, the patient developed a persistent headache. The patient was seen at a local urgent care facility on 27-Oct-2013 and was prescribed CEFDINIR for probable sinusitis. An unspecified physician added prednisone(manufacturer unknown) to therapy on 31-OCT-2013. The symptoms did not improve. In November 2013, a Computerised tomography scan of the head revealed swollen lymph nodes (disability). A mono test was positive. The patient has been on bed rest, unable to attend school, since November 2013. The patient was experiencing ear pain and extreme sensitivity to sound, intermittent nausea, and cold hands and feet. The outcome of swollen lymph nodes, cold hands and feet, intermittent nausea, extreme sensitivity to sound, ear pain and persistent headache was reported as not recovered. The causality for the events was not reported. Follow up information has been received from the pharmacist which stated that there has been no change to his daughter's condition. She was still bedridden, no energy and continued with the same symptoms for the last 4.5 months. The mononucleosis had been found following vaccination. The patient also had fatigue. The patient was having lab work done the day of the report. Results from MRI and CT scans (dates unspecified) were unremarkable. All reported events were considered as disability. It has been determined that case # 1402USA008807 is a duplicate of case # 1402USA004484. Therefore, case # 1402USA008807 is being deleted from our files and the cases consolidated into case # 1402USA004484. Additional information has been requested.
Age: 11.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Fatigue, Headache, Hyperacusis, Infectious mononucleosis, Lymphadenopathy
Clinical narrative: This spontaneous report as received from a pharmacist refers to a 11 year old female patient (daughter). The patients medical history included temporomandibular joint(June 2013). The patient, was administered her first dose of GARDASIL on 04-SEP-2013. On an unknown date in early October 2013, the patient developed a persistent headache. The patient was seen at a local urgent care facility on 27-Oct-2013 and was prescribed CEFDINIR for probable sinusitis. An unspecified physician added prednisone(manufacturer unknown) to therapy on 31-OCT-2013. The symptoms did not improve. In November 2013, a Computerised tomography scan of the head revealed swollen lymph nodes (disability). A mono test was positive. The patient has been on bed rest, unable to attend school, since November 2013. The patient was experiencing ear pain and extreme sensitivity to sound, intermittent nausea, and cold hands and feet. The outcome of swollen lymph nodes, cold hands and feet, intermittent nausea, extreme sensitivity to sound, ear pain and persistent headache was reported as not recovered. The causality for the events was not reported. Follow up information has been received from the pharmacist which stated that there has been no change to his daughter's condition. She was still bedridden, no energy and continued with the same symptoms for the last 4.5 months. The mononucleosis had been found following vaccination. The patient also had fatigue. The patient was having lab work done the day of the report. Results from MRI and CT scans (dates unspecified) were unremarkable. All reported events were considered as disability. It has been determined that case # 1402USA008807 is a duplicate of case # 1402USA004484. Therefore, case # 1402USA008807 is being deleted from our files and the cases consolidated into case # 1402USA004484. Additional information has been requested.